Philadelphia, PA -- June 23, 2017. Clarivate Analytics today announced a novel public/private strategic partnership with Impactstory that will remove a critical barrier for researchers: limited open access (OA) to high-quality, trusted peer-reviewed content. Under the terms of the partnership, Clarivate Analytics is providing a grant to Impactstory to build on its oaDOI service, making open access content more easily discoverable, and the research workflow more efficient from discovery through publishing.
The world of science publishing is complex. Researchers conducting online searches for scholarly articles frequently get unreliable results that can compromise their work. This is typically because the results omit journal articles behind paid-subscription paywalls or because "web-scraping" utilities return versions of articles that are not peer-reviewed or are in violation of copyright laws. The partnership between Clarivate Analytics and Impactstory will enable a more inclusive approach that provides researchers and institutions of all sizes with open access to trusted research, in a way that can be sustained across the broad science publishing ecosystem.
The oaDOI service is from Impactstory, a nonprofit creating online tools to make science more open and reusable. It currently indexes 90 million articles and delivers open-access full text versions over a free, fast, open API that is currently used by over 700 libraries worldwide and fulfills over 2 million requests daily. Impactstory has also built Unpaywall, a free browser extension that uses oaDOI to find full text whenever researchers come across paywalled articles.
"Clarivate Analytics is working to enhance research content and discovery with trusted, validated open access links, where they exist, to external, free full text open access versions of the literature," said Jay Nadler, CEO of Clarivate Analytics. "This partnership reflects our goal to be an innovative and collaborative brand, dedicated to the sharing of important research within the research community the legal, compliant way."
Clarivate is developing and delivering innovative analytics and workflow solutions that increase efficiencies across the entire research lifecycle; from idea to experiment, to peer review, to publication, dissemination and assessment. The partnership with Impactstory will accelerate the discovery phase of innovation for Clarivate customers by connecting researchers to verified versions of an estimated 18 million new open access articles from Web of Science. The enhanced open access knowledge base created by the partnership will be particularly valuable to smaller institutions.
"Our goal is to help remove barriers for researchers by giving them access to relevant, full text documents that aid in their research," said Heather Piwowar, co-founder of Impactstory. "With the grant from Clarivate, we're able to make over 18 million articles available to every researcher and library – those with subscriptions and those without."
"This novel partnership with the private sector advances our work to make scholarly research more available to everyone, advancing progress toward a more powerful, universally open science communication ecosystem," said Jason Priem, co-founder of Impactstory.
Clarivate Analytics accelerates the pace of innovation by providing trusted insights and analytics to customers around the world, enabling them to discover, protect and commercialize new ideas faster. Formerly the Intellectual Property and Science business of Thomson Reuters, we own and operate a collection of leading subscription-based businesses focused on scientific and academic research, patent analytics and regulatory standards, pharmaceutical and biotech intelligence, trademark protection, domain brand protection and intellectual property management. Clarivate Analytics is now an independent company with over 4,000 employees, operating in more than 100 countries and owns well‐known brands that include Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet, among others. For more information, please visit clarivate.com.